Paolo Tralongo

1.9k total citations
48 papers, 977 citations indexed

About

Paolo Tralongo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Paolo Tralongo has authored 48 papers receiving a total of 977 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Paolo Tralongo's work include Cancer survivorship and care (12 papers), Cancer Treatment and Pharmacology (9 papers) and Colorectal Cancer Treatments and Studies (8 papers). Paolo Tralongo is often cited by papers focused on Cancer survivorship and care (12 papers), Cancer Treatment and Pharmacology (9 papers) and Colorectal Cancer Treatments and Studies (8 papers). Paolo Tralongo collaborates with scholars based in Italy, United States and Argentina. Paolo Tralongo's co-authors include Francesco Ferraù, Vittorio Gebbia, Antonino Carmelo Tralongo, Ilaria Proserpio, Antonella Surbone, Giuseppe Luigi Banna, Lodovico Balducci, Paul B. Jacobsen, Christina Thors and Nicolò Borsellino and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Paolo Tralongo

43 papers receiving 950 citations

Peers

Paolo Tralongo

ONCOL

PRM

PPCH

Biswajit Dubashi India

Janise M. Roh United States

Raquel E. Reinbolt United States

Joseph Bubalo United States

M. A. Mangues Spain

Shayna L. Showalter United States

Francisco Batel Marques Portugal

Satoru Iwase Japan

Cheng‐Hsu Wang Taiwan

Karen Smith Blesch United States

Biswajit Dubashi India

Paolo Tralongo

268 ×0.5

ONCOL

115 ×0.5

PRM

117 ×0.8

60 ×0.4

135 ×1.0

PPCH

Citations per year, relative to Paolo Tralongo Paolo Tralongo (= 1×) peers Biswajit Dubashi

Countries citing papers authored by Paolo Tralongo

Since Specialization

Citations

This map shows the geographic impact of Paolo Tralongo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Tralongo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Tralongo more than expected).

Fields of papers citing papers by Paolo Tralongo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Tralongo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Tralongo. The network helps show where Paolo Tralongo may publish in the future.

Co-authorship network of co-authors of Paolo Tralongo

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Tralongo. A scholar is included among the top collaborators of Paolo Tralongo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Tralongo. Paolo Tralongo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pace, Andrea, Enrico Marchioni, Alessia Pellerino, et al.. (2024). Cancer-Related Cognitive Impairments (CRCIs) in Non-Central Nervous System Adult Patients: Outcome Measures and Methodology of Assessment: A Literature Review. Brain Sciences. 14(11). 1119–1119. 3 indexed citations

Maso, Luigino Dal, Armando Santoro, Paolo De Paoli, et al.. (2022). Cancer Cure and Consequences on Survivorship Care: Position Paper from the Italian Alliance Against Cancer (ACC) Survivorship Care Working Group. Cancer Management and Research. Volume 14. 3105–3118. 11 indexed citations

Tralongo, Paolo. (2021). SPECIAL ISSUE: THE 50th ANNIVERSARY OF THE NATIONAL CANCER ACT OF 1971 - OPINION PAPER - CANCER, A NEVER ENDING DISEASE?. SHILAP Revista de lepidopterología.

Gebbia, Vittorio, Roberto Bordonaro, Livio Blasi, et al.. (2020). Liability of clinical oncologists and the COVID-19 emergency: Between hopes and concerns. Journal of Cancer Policy. 25. 100234–100234. 5 indexed citations

Blasi, Livio, Roberto Bordonaro, Nicolò Borsellino, et al.. (2020). Reactions and countermeasures of medical oncologists towards the incoming COVID-19 pandemic: a WhatsApp messenger-based report from the Italian College of Chief Medical Oncologists. ecancermedicalscience. 14. 1046–1046. 10 indexed citations

Tralongo, Paolo, Antonella Surbone, Diego Serraino, & Luigino Dal Maso. (2019). Major patterns of cancer cure: Clinical implications. European Journal of Cancer Care. 28(6). e13139–e13139. 18 indexed citations

Valerio, Maria Rosaria, et al.. (2018). Hematologic toxicity of radium-223 in elderly patients with metastatic Castration Resistant Prostate Cancer: a real-life experience. Prostate International. 7(1). 25–29. 6 indexed citations

Berretta, Massimiliano, et al.. (2017). The Real Impact of Target Therapy in Breast Cancer Patients: Between Hope and Reality. Current Cancer Drug Targets. 18(5). 480–498. 4 indexed citations

Tralongo, Paolo, et al.. (2017). Physical Needs of Long-term Cancer Patients. Anticancer Research. 37(9). 4733–4746. 10 indexed citations

10.

Berretta, Massimiliano, Paolo Tralongo, Alberto Fulvi, et al.. (2016). Use of Complementary and Alternative Medicine (CAM) in cancer patients: an Italian multicenter Survey. Annals of Oncology. 27. iv113–iv113. 8 indexed citations

11.

Gernone, Angela, et al.. (2015). Optimal sequence of bone target drugs in metastatic prostatic cancer. Expert Review of Anticancer Therapy. 15(8). 923–929. 1 indexed citations

12.

Romano, Fabrizio, et al.. (2015). Metformin and Cancer Treatment. World Journal of Oncology. 6(1). 316–317. 1 indexed citations

13.

Gebbia, Vittorio, Giuseppe Luigi Banna, Paolo di Russo, et al.. (2013). Treatment Monitoring Program for Implementation of Adherence to Second-Line Erlotinib for Advanced Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 14(4). 390–398. 44 indexed citations

14.

Gebbia, Vittorio, Francesco Verderame, Francesco Ferraù, et al.. (2006). Raltitrexed plus levofolinic acid and bolus/continuous infusion 5-fluorouracil on a biweekly schedule for elderly patients with advanced colorectal carcinomas. Annals of Oncology. 17. vii60–vii65. 9 indexed citations

15.

Gebbia, Vittorio, Salvatore Del Prete, Nicolò Borsellino, et al.. (2006). Efficacy and Safety of Cetuximab/Irinotecan in Chemotherapy-Refractory Metastatic Colorectal Adenocarcinomas: A Clinical Practice Setting, Multicenter Experience. Clinical Colorectal Cancer. 5(6). 422–428. 24 indexed citations

16.

Costanzo, Francesco Di, Paolo Carlini, Laura Doni, et al.. (2005). Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC). British Journal of Cancer. 93(2). 185–189. 78 indexed citations

17.

Tralongo, Paolo, et al.. (2004). Safety of Long-Term Administration of Bisphosphonates in Elderly Cancer Patients. Oncology. 67(2). 112–116. 18 indexed citations

18.

Tralongo, Paolo, et al.. (2003). Fatigue and aging. Critical Reviews in Oncology/Hematology. 48(Suppl). S57–S64. 42 indexed citations

19.

Jacobsen, Paul B., et al.. (2003). The prevalence and correlates of fatigue in older cancer patients. Critical Reviews in Oncology/Hematology. 47(3). 273–279. 75 indexed citations

20.

Damascelli, B, Alfonso Marchianò, Carlo Spreafico, et al.. (1990). Circadian continuous chemotherapy of renal cell carcinoma with an implantable, programmable infusion pump. Cancer. 66(2). 237–241. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact